• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharmaceuticals

Novo Nordisk A/S

+ Add to Watchlist


45.4000 USD 0.0500 0.11%

As of 20:04:07 ET on 07/09/2014.

Snapshot for Novo Nordisk A/S (NVO)

Open: 45.1400 Day's Range: 45.1000 - 45.4700 Volume: 1,352,611
Previous Close: 45.4500 52wk Range: 31.6340 - 48.4200 1-Yr Rtn: +43.16%

Stock Chart for NVO

No chart data available.
  • NVO:US 45.4000
  • 1D
  • 1M
  • 1Y
Interactive NVO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NVO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 24.5107
Relative P/E vs. SPX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2014) 10.1470
Est. PEG Ratio 2.2068
Market Cap (M USD) 120,310.00
Shares Outstanding (M) 2,112.56
30 Day Average Volume 827,021
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.83%
Cash Dividend (USD) 0.6061
Dividend Ex-Date 03/21/2014
5 Year Dividend Growth 31.13%
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NVO

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for NVO

Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.

Lars Rebien SorensenChief Executive OfficerKaare SchultzPresident/COO
Jesper BrandgaardExec VP/CFOLars Fruergaard JorgensenExec VP/CIO
More Company Profile & Key Executives for NVO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil